Tamer, F. And Gülekon, A. 2022. Tuberculosis screening guidelines should be updated and quantiferon test should be a prerequisite prior to the initiation of treatment of psoriasis with biological agents. European Review for Medical and Pharmacological Sciences , vol.26, no.23 , 8788-8794.

Tamer, F., & Gülekon, A., (2022). Tuberculosis screening guidelines should be updated and quantiferon test should be a prerequisite prior to the initiation of treatment of psoriasis with biological agents. European Review for Medical and Pharmacological Sciences , vol.26, no.23, 8788-8794.

Tamer, FUNDA, And AYLA GÜLEKON. "Tuberculosis screening guidelines should be updated and quantiferon test should be a prerequisite prior to the initiation of treatment of psoriasis with biological agents," European Review for Medical and Pharmacological Sciences , vol.26, no.23, 8788-8794, 2022

Tamer, FUNDA And Gülekon, AYLA. "Tuberculosis screening guidelines should be updated and quantiferon test should be a prerequisite prior to the initiation of treatment of psoriasis with biological agents." European Review for Medical and Pharmacological Sciences , vol.26, no.23, pp.8788-8794, 2022

Tamer, F. And Gülekon, A. (2022) . "Tuberculosis screening guidelines should be updated and quantiferon test should be a prerequisite prior to the initiation of treatment of psoriasis with biological agents." European Review for Medical and Pharmacological Sciences , vol.26, no.23, pp.8788-8794.

@article{article, author={FUNDA TAMER And author={AYLA GÜLEKON}, title={Tuberculosis screening guidelines should be updated and quantiferon test should be a prerequisite prior to the initiation of treatment of psoriasis with biological agents}, journal={European Review for Medical and Pharmacological Sciences}, year=2022, pages={8788-8794} }